New Rhein Healthcare Investors
New Rhein Healthcare Investors is a venture capital firm that applies a private equity business model to life sciences investing. The firm focuses on assets with proven clinical safety and efficacy, applied in innovative ways such as new delivery forms or indications. New Rhein aims to develop products that offer significant health benefits to patients and economic value to payors. The firm takes significant stakes in a small number of companies, actively managing their value creation to limit science-based risk and concentrate on successful product development and commercialization.
Industries
N/A
Nr. of Employees
small (1-50)
New Rhein Healthcare Investors
Two Logan Square, Suite 1930, Philadelphia PA 19103
Portfolio
Developing a prodrug of treprostinil delivered on a proprietary transdermal patch to treat pulmonary arterial hypertension (PAH).
#Pharmaceuticals
US-based sterile injectable manufacturer focused on ready-to-use pre-filled syringes and vials.
#Pharmaceuticals
Developing a minimally invasive implantable device for the treatment of benign prostatic hyperplasia (BPH).
#Medical Devices
Developing an innovative polyethylene-glycol fusion technology to improve surgical outcomes in traumatic nerve injuries.
#Biotechnology
Developing a proprietary hand-held soft-mist inhaler for the treatment of asthma and COPD.
#Pharmaceuticals
Developing a prodrug of treprostinil delivered on a proprietary transdermal patch to treat pulmonary arterial hypertension (PAH).
#Pharmaceuticals
US-based sterile injectable manufacturer focused on ready-to-use pre-filled syringes and vials.
#Pharmaceuticals
Developing a minimally invasive implantable device for the treatment of benign prostatic hyperplasia (BPH).
#Medical Devices
Developing an innovative polyethylene-glycol fusion technology to improve surgical outcomes in traumatic nerve injuries.
#Biotechnology
Developing a proprietary hand-held soft-mist inhaler for the treatment of asthma and COPD.
#Pharmaceuticals